Radiolabeled Compounds for Diagnosis and Treatment of Cancer

• Outros Autores: Kumar, Krishan (Editor)
• Formato: Recurso Eletrônico Capítulo de Livro
• Idioma: inglês
• Publicado em: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
• Assuntos: Research & information: general; Chemistry; positron emission tomography (PET); pyrazoles; fluorine-18; radionuclides; PET probes; imaging pharmaceuticals; hypopharyngeal cancer; 188Re-liposome; repeated therapy; NGS; microRNA; aprepitant; radiopharmaceuticals; neurokinin 1 receptor antagonist; radionuclide chelators; kidney uptake; cleavable linkers; neutral endopeptidase (NEP); renal brush border enzymes; prostate-specific membrane antigen (PSMA); cancer imaging and therapy; somatostatin analogs; radiolabeling; radionuclide therapy; imaging; adrenergic receptor; positron emission tomography; radiotracer; cholecystokinin-2 receptor; minigastrin; molecular imaging; targeted radiotherapy; lutetium-177; EpCAM; radionuclide; SPECT; iodine; PIB; breast; cancer; PET; target-specific biomolecules; immunoPET imaging pharmaceuticals; production processes; 124I-labeled monoclonal antibodies; radiotracers; AAZTA; scandium-44; FAP; SA; DPP; PREP; radioiodine labeling; radioiodination; biomolecules; peptides; proteins; monoclonal antibodies; 123,124,125,131I-labeled molecules and biomolecules; n/a
• Acesso em linha: DOAB: download the publication; DOAB: description of the publication

Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developi...